Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Functional Studies on the Novel R2TP Chaperone Complex

FY 2022-23

Summary
Ensuring the proper folding and assembly of proteins is essential for maintaining cellular homeostasis. This task is accomplished by a complex network of molecular chaperones, including the highly conserved Hsp90 chaperone complex. Hsp90, in conjunction with other chaperones and cochaperones, works to maintain proteostasis and has been implicated in many diseases. Our group recently discovered the R2TP chaperone complex consisting of RUVBL1-RUVBL2-RPAP3-PIH1D1, which interacts with Hsp90 to mediate the assembly of various macromolecular complexes including snoRNPs, and PIKKs such as mTOR and SMG1. Currently, a detailed mechanism of function for R2TP is unknown. Thus, my research will focus on characterizing and understanding the function of this chaperone complex with the aim of developing the first established activity assay specific to R2TP. This will be done by assessing the interactions between R2TP and established protein complexes such as the TTT (TELO2-TTI1-TTI2) complex. This will be accomplished using various experimental techniques including gel filtration experiments to determine if R2TP is responsible for TTT assembly and fluorescence experiments to monitor the rate of assembly of the TTT complex. Lastly, RNAi technology will be used to generate knockdowns of the R2TP subunits to determine the effects on TTT assembly. Furthermore, the overactivation of several R2TP substrates has been linked to many cancers, therefore, R2TP remains an excellent target for anticancer drug development. For this reason, a high throughput ATPase activity assay will be used to screen for inhibitors of RUVBL1/2 ATPase activity. These inhibitors will be used in cell-based studies and could be developed further to target the various R2TP oncogenic client proteins.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
490911
Name
Mohamed Maryama
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functional Studies on the Novel R2TP Chaperone Complex
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Activity Assay; Cancer; Drug Development; Hsp90; Molecular Chaperones; R2tp
Abstract
Ensuring the proper folding and assembly of proteins is essential for maintaining cellular homeostasis. This task is accomplished by a complex network of molecular chaperones, including the highly conserved Hsp90 chaperone complex. Hsp90, in conjunction with other chaperones and cochaperones, works to maintain proteostasis and has been implicated in many diseases. Our group recently discovered the R2TP chaperone complex consisting of RUVBL1-RUVBL2-RPAP3-PIH1D1, which interacts with Hsp90 to mediate the assembly of various macromolecular complexes including snoRNPs, and PIKKs such as mTOR and SMG1. Currently, a detailed mechanism of function for R2TP is unknown. Thus, my research will focus on characterizing and understanding the function of this chaperone complex with the aim of developing the first established activity assay specific to R2TP. This will be done by assessing the interactions between R2TP and established protein complexes such as the TTT (TELO2-TTI1-TTI2) complex. This will be accomplished using various experimental techniques including gel filtration experiments to determine if R2TP is responsible for TTT assembly and fluorescence experiments to monitor the rate of assembly of the TTT complex. Lastly, RNAi technology will be used to generate knockdowns of the R2TP subunits to determine the effects on TTT assembly. Furthermore, the overactivation of several R2TP substrates has been linked to many cancers, therefore, R2TP remains an excellent target for anticancer drug development. For this reason, a high throughput ATPase activity assay will be used to screen for inhibitors of RUVBL1/2 ATPase activity. These inhibitors will be used in cell-based studies and could be developed further to target the various R2TP oncogenic client proteins.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mohamed, Maryama
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~